Page last updated: 2024-08-23

zidovudine and Acute Lymphoid Leukemia

zidovudine has been researched along with Acute Lymphoid Leukemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, FE; Chen, WX; De Clercq, E; He, QQ; Pannecouque, C; Piao, HR; Wu, HQ; Wu, Y; Yan, ZH1
Bozzi, A; Carnicelli, V; Di Giulio, A; Franceschini, N; Gualtieri, G; Lizzi, AR1
Balagopala, MI; Lee, HJ; Ollapally, AP1
Astigarraga, I; Cardenal, I; Fernández-Teijeiro, A; Navajas, A; Piñán, MA1
Moschovi, M; Papaevangelou, V; Theodoridou, M; Tzortzatou-Stathopoulou, F1

Other Studies

5 other study(ies) available for zidovudine and Acute Lymphoid Leukemia

ArticleYear
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Bioorganic & medicinal chemistry, 2014, Jun-15, Volume: 22, Issue:12

    Topics: Anti-HIV Agents; Benzamides; Cell Survival; Cells, Cultured; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured; Virus Replication

2014
Effects of azidothymidine on protein kinase C activity and expression in erythroleukemic cell K562 and acute lymphoblastic leukemia cell HSB-2.
    Acta biochimica et biophysica Sinica, 2015, Volume: 47, Issue:4

    Topics: Anti-HIV Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immunoblotting; K562 Cells; Leukemia, Erythroblastic, Acute; Membrane Fluidity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase C beta; Protein Kinase C-alpha; Tetradecanoylphorbol Acetate; Time Factors; Zidovudine

2015
Synthesis and anti-HIV activity of steroidal prodrugs of 3'-azido-3'-deoxythymidine (AZT).
    Cellular and molecular biology (Noisy-le-Grand, France), 1995, Volume: 41 Suppl 1

    Topics: Androstenols; Antiviral Agents; Biotransformation; CD4-Positive T-Lymphocytes; Cell Survival; Drug Evaluation, Preclinical; HIV-1; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prodrugs; Tumor Cells, Cultured; Zidovudine

1995
[Acute lymphoblastic leukemia with L1 morphology arising during treatment for ALL-L3 in a child with AIDS].
    Sangre, 1996, Volume: 41, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Child, Preschool; Fatal Outcome; Humans; Immunophenotyping; Male; Neoplasms, Second Primary; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Zidovudine

1996
Acute lymphoblastic leukaemia in an infant exposed to zidovudine in utero and early infancy.
    AIDS (London, England), 2000, Oct-20, Volume: 14, Issue:15

    Topics: Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pregnancy; Prenatal Exposure Delayed Effects; Zidovudine

2000